Aquestive Therapeutics ($AQST) Insider Trading & Smart Money Activity
Aquestive Therapeutics, Inc. ($AQST) has 4 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($335.10K), net -$335.10K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$335.10K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
AQST insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $229.50K | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $105.60K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All AQST insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Daniel BarberPresident and CEO | Sell (Open-market sale) 10b5-1 | 25K sh | $105.60K | Read | ||||||
| Insider | Julie Krop | Sell (Open-market sale) 10b5-1 | 25K sh | $125.50K | -17.3% | -25.0% | Read | ||||
| Insider | Julie Krop | Buy (Option exercise) | 25K sh | $17.75K | -17.3% | -25.0% | Read | ||||
| Insider | Daniel BarberPresident and CEO | Sell (Open-market sale) 10b5-1 | 25K sh | $104K | +11.8% | -6.4% | — | ||||
| 13F | Rtw Investments | Added | +1.18M sh | $30.89M | -1.2% | +1.2% | Read | ||||
| 13F | Rtw Investments | Added | +1.18M sh | $30.97M | -1.2% | +1.2% | Read |
1W / 1M / 6M = how AQST moved from the trade or filing date.
Insider trading in AQST: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Daniel Barber | President and CEO | 2 | -$209.60K | Oct 15, 2026 | |
| Julie Krop | 2 | -$125.50K | Jun 23, 2026 |
Institutions moving AQST (13F)
Frequently asked questions
Are AQST insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 3 open-market sales worth $335.10K, a net -$335.10K.
What is the latest insider trade in AQST?
Daniel Barber, President and CEO filed a sell (open-market sale) of 25K sh worth $105.60K on Oct 15, 2026.
Which institutions changed their AQST positions?
Recent 13F filers moving the stock include Rtw Investments.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.